Update on pulmonary disease due to non-tuberculous mycobacteria

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Jason E StoutWing Wai Yew

Abstract

Non-tuberculous mycobacteria (NTM) are emerging worldwide as significant causes of chronic pulmonary infection, posing a number of challenges for both clinicians and researchers. While a number of studies worldwide have described an increasing prevalence of NTM pulmonary disease over time, population-based data are relatively sparse and subject to ascertainment bias. Furthermore, the disease is geographically heterogeneous. While some species are commonly implicated worldwide (Mycobacterium avium complex, Mycobacterium abscessus), others (e.g., Mycobacterium malmoense, Mycobacterium xenopi) are regionally important. Thoracic computed tomography, microbiological testing with identification to the species level, and local epidemiology must all be taken into account to accurately diagnose NTM pulmonary disease. A diagnosis of NTM pulmonary disease does not necessarily imply that treatment is required; a patient-centered approach is essential. When treatment is required, multidrug therapy based on appropriate susceptibility testing for the species in question should be used. New diagnostic and therapeutic modalities are needed to optimize the management of these complicated infections.

Associated Clinical Trials

References

Sep 28, 1989·The New England Journal of Medicine·D S PrinceJ E Fish
May 1, 1995·Journal of Computer Assisted Tomography·D A LynchM J Heinig
Jun 1, 1994·American Journal of Respiratory and Critical Care Medicine·T P Kennedy, D J Weber
May 1, 1993·The American Review of Respiratory Disease·D E GriffithR J Wallace
Jun 1, 1997·American Journal of Respiratory and Critical Care Medicine·E TanakaF Kuze
Jan 3, 2001·The Journal of Infectious Diseases·R VankayalapatiP F Barnes
Nov 20, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Seigo KitadaKazuo Kobayashi
Dec 6, 2003·American Journal of Respiratory and Critical Care Medicine·Peadar G NooneMichael R Knowles
Jun 5, 2004·The European Respiratory Journal·M T HenryJ P Watson
Dec 14, 2004·American Journal of Respiratory and Critical Care Medicine·David M RodmanJerry A Nick
Dec 23, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Agnès FerroniJean-Louis Gaillard
Jan 12, 2005·Clinical and Diagnostic Laboratory Immunology·Seigo KitadaKazuo Kobayashi
Apr 13, 2005·The Journal of Antimicrobial Chemotherapy·Remedios GunaRafael Borrás
Oct 18, 2005·Thorax·M WickremasingheR Wilson
Mar 4, 2006·American Journal of Respiratory and Critical Care Medicine·Phung K LamAntonino Catanzaro
Apr 14, 2006·The European Respiratory Journal·H KunstR Wilson
Jul 22, 2006·American Journal of Respiratory and Critical Care Medicine·David E GriffithRichard J Wallace
Oct 27, 2006·FEMS Immunology and Medical Microbiology·Enrico Tortoli
Dec 23, 2006·American Journal of Respiratory and Critical Care Medicine·Tanyalak ParimonDavid H Au
Feb 6, 2007·American Journal of Respiratory and Critical Care Medicine·David E GriffithUNKNOWN Infectious Disease Society of America
Jun 30, 2007·Nature Clinical Practice. Rheumatology·Jakko van IngenDick van Soolingen
Dec 15, 2007·American Journal of Respiratory and Critical Care Medicine·Seigo KitadaUNKNOWN MAC Serodiagnosis Study Group
Jan 2, 2008·The European Respiratory Journal·J van IngenD van Soolingen
Feb 26, 2008·Journal of Tropical Pediatrics·F PalvoD Solé
Mar 8, 2008·Emerging Infectious Diseases·Jakko van IngenDick van Soolingen
Mar 8, 2008·Emerging Infectious Diseases·Ethan E BodleLisa Saiman
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jakko van IngenDick van Soolingen
Jun 6, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maeve P MurrayAdam T Hill
Jan 16, 2009·Respirology : Official Journal of the Asian Pacific Society of Respirology·Rachel M Thomson, Wing-Wai Yew

❮ Previous
Next ❯

Citations

Sep 19, 2016·Revue des maladies respiratoires·D HuetC Andréjak
Nov 5, 2016·Diagnostic Microbiology and Infectious Disease·Seong Mi MoonWon-Jung Koh
Dec 25, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Won-Jung KohO Jung Kwon
May 20, 2017·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Suk Hyeon JeongWon-Jung Koh
Dec 22, 2017·BMC Pulmonary Medicine·Jong Sik LeeJae-Joon Yim
Apr 18, 2018·Antimicrobial Agents and Chemotherapy·Byung Woo JhunWon-Jung Koh
Jul 3, 2018·The Annals of Otology, Rhinology, and Laryngology·Hannah KavookjianPamela Nicklaus
Aug 3, 2018·British Journal of Hospital Medicine·S RokadiyaS Tiberi
Aug 3, 2016·Antimicrobial Agents and Chemotherapy·Byeong-Ho JeongWon-Jung Koh
Mar 30, 2017·Antimicrobial Agents and Chemotherapy·Bumhee YangWon-Jung Koh
Jul 18, 2018·Antimicrobial Agents and Chemotherapy·Byoung Soo KwonKyung-Wook Jo
Jul 1, 2017·Journal of Clinical Microbiology·Hansong ChaeSung Jae Shin
Sep 27, 2018·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Mehdi DavariAbolfazl Fateh
Jun 8, 2018·American Journal of Respiratory and Critical Care Medicine·Byung Woo JhunWon-Jung Koh
Dec 12, 2018·PloS One·Steven A CowmanMichael R Loebinger
Dec 5, 2018·Antimicrobial Agents and Chemotherapy·Barbara A Brown-Elliott, Richard J Wallace
Feb 13, 2019·The Journal of Antimicrobial Chemotherapy·Vladyslav NikolayevskyyKatharina Kranzer
Feb 25, 2018·Infection·Tatjana Adzic-VukicevicSalvatore Rubino
Jan 4, 2019·Antimicrobial Agents and Chemotherapy·Mary P ChoulesSanghyun Cho
Jul 13, 2018·European Respiratory Review : an Official Journal of the European Respiratory Society·Martina ContariniJames D Chalmers
Mar 24, 2018·The European Respiratory Journal·Jakko van IngenUNKNOWN for NTM-NET
Nov 8, 2018·ERJ Open Research·Emily E RicottaJennifer Adjemian
Apr 28, 2017·The European Respiratory Journal·Roland DielFelix C Ringshausen
May 1, 2019·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Lilian Regina Macelloni MarquesÉrica Chimara
Apr 24, 2019·Antimicrobial Agents and Chemotherapy·Augusto Cesar Hunt-SerracinCara C Boutte
Jun 21, 2019·Pharmaceuticals·Pierre LaumailléPascal Sonnet
Oct 20, 2019·International Journal of Environmental Research and Public Health·Helena ModráIvo Pavlík
Dec 31, 2019·The Journal of Antimicrobial Chemotherapy·Mike Marvin RuthJakko van Ingen
Sep 29, 2019·Arthritis Care & Research·Naomi Serling-BoydEli M Miloslavsky
Jan 23, 2020·Antimicrobial Agents and Chemotherapy·Jickky Palmae SarathyThomas Dick
Apr 16, 2020·The Journal of Antimicrobial Chemotherapy·Camron PearceJakko van Ingen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Journal of Thoracic Disease
Margaret M Johnson, John A Odell
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
Yu-Jung TungYen-Hsu Chen
Enfermedades infecciosas y microbiología clínica
Fernando Alcaide, Jaime Esteban
© 2021 Meta ULC. All rights reserved